The Ophthalmic Physician Newsletter

Connect

Help Build A New Platform For Learning I'm thrilled to announce the launch of Ophthalmic Physician’s Virtual Course Academy, an innovative lesson-based modular platform designed specifically to deepen knowledge and expertise in medical diagnostics and primary eye care. What You Can Expect: Int...

by John R Martinelli MD OD FAAO — Oct 13, 2024

Geographic Atrophy & AREDS

Does supplementation matter?... A study published in Ophthalmology has found promising results in the management of a particular subtype of age-related macular degeneration (AMD). Oral antioxidant and lutein/zeaxanthin supplements, specifically the AREDS2 formulation, have demonstrated signific...

by John R Martinelli MD OD FAAO — Oct 11, 2024

Brain Atrophy & AMD

Could this be a new biomarker?... An article published in the American Journal of Ophthalmology last week reveals a significant association between outer retinal thinning and brain atrophy in early age-related macular degeneration (AMD). This correlation, particularly strong in vision-related b...

by John R Martinelli MD OD FAAO — Oct 10, 2024

Future of nAMD on the Horizon

Intravitreal injections no more?... Neovascular age-related macular degeneration (nAMD) remains a significant cause of vision loss worldwide, with current anti-VEGF therapies facing challenges such as frequent injections and inadequate long-term responses. Recent advances in nAMD treatment are ...

by John R Martinelli MD OD FAAO — Oct 09, 2024

Home OCT?

Is this the future?... A recent prospective trial published in Retina investigating home optical coherence tomography (OCT)-guided management of neovascular age-related macular degeneration (nAMD) has yielded promising results. The study, involving 15 patients over 6 months, demonstrated a sig...

by John R Martinelli MD OD FAAO — Oct 08, 2024

Alpha-adrenergics & Iris Dynamics

Does it really matter in cataract surgery?... A study published last week in BMC Ophthalmology revists alpha-adrenergic antagonists, commonly prescribed for hypertension and benign prostatic hyperplasia, and if they truly pose significant challenges during cataract surgery. These medications,...

by John R Martinelli MD OD FAAO — Oct 07, 2024

Ocular Toxicity & Systemic Medication

A Friendly Reminder... Ocular toxicity due to systemic medication can present a significant challenge in daily practice, requiring appropriate management and interdisciplinary collaboration. We should be reminded to fully understand the pharmacology of each and every medication our patients are...

by John R Martinelli MD OD FAAO — Oct 04, 2024

Purtscher-Like Retinopathy with Systemic Lupus Erythematosus

BMC Ophthalmology recently published a case of a 25-year-old patient who presented with sudden bilateral vision loss, revealing a rare case of simultaneous bilateral Purtscher-like retinopathy associated with systemic lupus erythematosus (SLE). Exam showed retinal edema, artery narrowing, and s...

by John R Martinelli MD OD FAAO — Oct 03, 2024

Retinal O2 Saturation & Glaucomatous VF Defects

The Journal of Glaucoma recently published findings which found a counterintuitive relationship but significant correlation between retinal oxygen saturation (StO2) and the severity of visual field loss in glaucoma patients. A study utilizing novel diffuse reflectance spectroscopy found higher...

by John R Martinelli MD OD FAAO — Oct 02, 2024

Air Pollution and Glaucoma

A systematic review published today has highlighted the significant impact of environmental factors on glaucoma progression, helping to expand our understanding beyond traditional risk factors like intraocular pressure (IOP). Studies have identified several key environmental influences, includi...

by John R Martinelli MD OD FAAO — Sep 30, 2024

Glaucoma Treatment & Alzheimers' Risk

Recent findings published just today in Nature: Eye has uncovered a concerning link between certain glaucoma medications and Alzheimers' disease (AD) risk. A nationwide cohort study in Taiwan found glaucoma patients using topical alpha-2 adrenergic agonists had a significantly higher risk of d...

by John R Martinelli MD OD FAAO — Sep 29, 2024

Effect of Cannabis Usage on Thyroid Eye Disease

Findings published last month in Ophthalmic Plastic & Reconstructive Surgery has shown a potential link between cannabis usage and thyroid eye disease (TED) in patients with autoimmune hyperthyroidism. A cohort study utilizing electronic health records examined 36,186 patients over a 20-year per...

by John R. Martinelli MD OD FAAO — Sep 28, 2024

1 2 3 4 5 6 7 8 9

The Ophthalmic Physician Newsletter

Building A New Class Of Physician.